$6.44
0.05[0.78%]
At close: Apr 24
$6.44
0[0.00%]
After Hours: 9:19AM EDT
Werewolf Therapeutics
(NASDAQ:HOWL)Werewolf Therapeutics Stock (NASDAQ:HOWL), Analyst Ratings, Price Targets, Predictions
Werewolf Therapeutics Inc has a consensus price target of $17.43, established from looking at the 26 latest analyst ratings. The last 3 analyst ratings were released from JMP Securities, HC Wainwright & Co., and HC Wainwright & Co. on April 3, 2024, March 7, 2024, and November 15, 2023. With an average price target of $14 between JMP Securities, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 117.39% upside for Werewolf Therapeutics Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
JMP Securities
HC Wainwright & Co.
Wedbush
EF Hutton
B of A Securities
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Werewolf Therapeutics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/03/2024 | HOWL | Buy Now | Werewolf Therapeutics | $6.44 | 86.34% | JMP Securities | Reni Benjamin | → $12 | Initiates | → Market Outperform | Get Alert |
| 03/07/2024 | HOWL | Buy Now | Werewolf Therapeutics | $6.44 | 132.92% | HC Wainwright & Co. | Andres Maldonado | $15 → $15 | Maintains | Buy | Get Alert |
| 11/15/2023 | HOWL | Buy Now | Werewolf Therapeutics | $6.44 | 132.92% | HC Wainwright & Co. | Andres Maldonado | → $15 | Reiterates | Buy → Buy | Get Alert |
| 10/31/2023 | HOWL | Buy Now | Werewolf Therapeutics | $6.44 | 132.92% | HC Wainwright & Co. | Andres Maldonado | → $15 | Reiterates | Buy → Buy | Get Alert |
| 09/19/2023 | HOWL | Buy Now | Werewolf Therapeutics | $6.44 | 132.92% | HC Wainwright & Co. | Andres Maldonado | → $15 | Reiterates | Buy → Buy | Get Alert |
| 09/15/2023 | HOWL | Buy Now | Werewolf Therapeutics | $6.44 | 132.92% | HC Wainwright & Co. | Andres Maldonado | → $15 | Reiterates | Buy → Buy | Get Alert |
| 08/24/2023 | HOWL | Buy Now | Werewolf Therapeutics | $6.44 | 39.75% | Wedbush | Robert Driscoll | → $9 | Initiates | → Outperform | Get Alert |
| 08/10/2023 | HOWL | Buy Now | Werewolf Therapeutics | $6.44 | 132.92% | HC Wainwright & Co. | Andres Maldonado | → $15 | Reiterates | Buy → Buy | Get Alert |
| 05/25/2023 | HOWL | Buy Now | Werewolf Therapeutics | $6.44 | 28.88% | EF Hutton | Michael King | → $8.3 | Assumes | → Buy | Get Alert |
| 05/12/2023 | HOWL | Buy Now | Werewolf Therapeutics | $6.44 | 55.28% | B of A Securities | Jason Zemansky | $9 → $10 | Maintains | Buy | Get Alert |
| 05/11/2023 | HOWL | Buy Now | Werewolf Therapeutics | $6.44 | 132.92% | HC Wainwright & Co. | Andres Maldonado | → $15 | Reiterates | Buy → Buy | Get Alert |
| 03/24/2023 | HOWL | Buy Now | Werewolf Therapeutics | $6.44 | 28.88% | EF Hutton | Michael King | → $8.3 | Reiterates | → Buy | Get Alert |
| 03/23/2023 | HOWL | Buy Now | Werewolf Therapeutics | $6.44 | 39.75% | B of A Securities | Jason Zemansky | → $9 | Reiterates | Buy → Buy | Get Alert |
| 03/23/2023 | HOWL | Buy Now | Werewolf Therapeutics | $6.44 | 132.92% | HC Wainwright & Co. | Andres Maldonado | $20 → $15 | Reiterates | → Buy | Get Alert |
| 02/27/2023 | HOWL | Buy Now | Werewolf Therapeutics | $6.44 | 28.88% | EF Hutton | Michael King | → $8.3 | Reiterates | → Buy | Get Alert |
| 02/17/2023 | HOWL | Buy Now | Werewolf Therapeutics | $6.44 | 28.88% | EF Hutton | Michael King | → $8.3 | Reiterates | → Buy | Get Alert |
| 01/30/2023 | HOWL | Buy Now | Werewolf Therapeutics | $6.44 | 24.22% | B of A Securities | Jason Zemansky | $9 → $8 | Maintains | Buy | Get Alert |
| 12/05/2022 | HOWL | Buy Now | Werewolf Therapeutics | $6.44 | 28.88% | EF Hutton | Michael King | → $8.3 | Initiates | → Buy | Get Alert |
| 06/02/2022 | HOWL | Buy Now | Werewolf Therapeutics | $6.44 | 210.56% | HC Wainwright & Co. | Andres Maldonado | → $20 | Assumes | → Buy | Get Alert |
FAQ
What is the target price for Werewolf Therapeutics (HOWL)?
The latest price target for Werewolf Therapeutics (NASDAQ: HOWL) was reported by JMP Securities on April 3, 2024. The analyst firm set a price target for $12.00 expecting HOWL to rise to within 12 months (a possible 86.34% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Werewolf Therapeutics (HOWL)?
The latest analyst rating for Werewolf Therapeutics (NASDAQ: HOWL) was provided by JMP Securities, and Werewolf Therapeutics initiated their market outperform rating.
When was the last upgrade for Werewolf Therapeutics (HOWL)?
There is no last upgrade for Werewolf Therapeutics.
When was the last downgrade for Werewolf Therapeutics (HOWL)?
There is no last downgrade for Werewolf Therapeutics.
When is the next analyst rating going to be posted or updated for Werewolf Therapeutics (HOWL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Werewolf Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Werewolf Therapeutics was filed on April 3, 2024 so you should expect the next rating to be made available sometime around April 3, 2025.
Is the Analyst Rating Werewolf Therapeutics (HOWL) correct?
While ratings are subjective and will change, the latest Werewolf Therapeutics (HOWL) rating was a initiated with a price target of $0.00 to $12.00. The current price Werewolf Therapeutics (HOWL) is trading at is $6.44, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.